Home TechnologyPolyclonal Antibodies

Polyclonal Antibodies

Polyclonal antibodies are antibodies that are derived from different B-cell lines. They are a mixture of immunoglobulin molecules secreted against a specific antigen, each recognising a different epitope.

These antibodies are typically produced by immunization of a suitable mammal, such as a mouse, rabbit or goat. Larger mammals are often preferred as the amount of serum that can be collected is greater. An antigen is injected into the mammal. This induces the B-lymphocytes to produce IgG immunoglobulins specific for the antigen. This IgG is purified from the mammal’s serum.

Physician-based Point of Care Diagnostics: Products and Outlook to 2017

The market for Point-of-Care (POC) diagnostic products used in the physician's surgery was worth approximately US$1.7 billion in 2011 with sectors such as cholesterol testing and tumour markers making the best continued growth in the year. All sectors will see sustained growth over the medium term, with the total addressable market for products that can be potentially used in a physician's office forging ahead to be valued at over US$6.1 billion by 2017.

2012 Nov: New Medical Device for the Detection of Multiple Diseases HBsAg, HVC and HIV.

November 2012 NewsWire: AT First Diagnostic LLC annouced that its in the near development of new medical device for rapid clinical screening of Hepatitis B virus (HBV), Hepatitis C virus (HCV) and HIV test kit using one whole blood sample from a simple finger pick.

Walter Reed Concludes FirstVue's HBSAG Test is Preferred over Others...

Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests FirstVue(TM) HBSAG Test Found to Have Higher Sensitivity and Specificity than Other Rapid HBSAG Tests and FirstVue(TM) “ …and was the preferred test in all phases of this evaluation”

Distributor Login

By Condition

Twitter

The lateral-flow point-of-care (POC) test market is expected to grow steadily and increase by more than 40% in five years.

by FirstVue Corporation

Firstvue Corporation has launched a new brand identity for the Company along with a redesigned website at http://t.co/jmac04NY

by FirstVue Corporation

Point-of-Care Value $16.5 billion in 2016

The global market for point-of-care diagnostics, valued at $13.8 billion in 2011, is expected to increase to $16.5 billion in 2016, according to a new report Point-of-Care Diagnostics from BCC Research.

The market for point-of-care (POC) diagnostics can be broken down into 10 segments: glucose monitoring, blood chemistry and electrolyte, pregnancy and fertility, cardiac markers, drug and alcohol, infectious disease, cholesterol, hemoglobin/hemostasis, urine chemistry and tumor marker.

As this site can be accessed from various countries around the world. Availability of Products: Reference to any product or service on the site does not constitute an offer to sell or supply that product or service. Specific advice concerning the availability and suitability of any particular product or service should be sought before purchase. We reserve the right to make any changes and corrections to this site as and when we consider it appropriate and without notice.